Management Prospects for COVID-19: A Review

Uzma Aamir Jilani, Ishrat Rahman and Syed Aamir Jilani
Additional contact information
Uzma Aamir Jilani: Management & Science University
Ishrat Rahman: Department of Basic Dental Sciences, College of Dentistry, Princess Nourah bint Abdulrahman University
Syed Aamir Jilani: Dublin Business School

Technium, 2020, vol. 2, issue 7, 118-127

Abstract: Although the number of active COVID-19 cases have been fallen in some countries, the threat of the pandemic is still impending in many parts of the world and the pace of recovery is still uncertain. SARS-CoV-2 outbreak has expanded very quickly since the beginning of 2020 and has now taken approximately a million lives all around the globe. Sadly, there is yet to be an approved treatment for COVID-19 as it may take a few years to establish a definitive treatment and a vaccine against SARS-CoV-2. This study aims to review the preventive and curative measures currently under investigation for COVID-19 and the targeted pathogenic features of the SARS-CoV-2. To manage the clinical implications of COVID-19, and to alleviate SARS-CoV-2, the main focus is on supportive therapy, symptom control, antiviral drugs, and immunomodulation. Intense research activities for therapeutic interventions are in progress worldwide to evaluate the benefit of such drugs.

Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
https://techniumscience.com/index.php/technium/article/view/1776 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:tec:techni:ojs:1776

DOI: 10.47577/technium.v2i7.1776

Access Statistics for this article

Technium is currently edited by Scurtu Ionut Cristian

More articles in Technium from Technium Science
Bibliographic data for series maintained by Ana Maria Golita ().